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Objective: To estimate the current and future (to year 2032) impact of osteoarthritis (OA) health care
seeking.
Method: Population-based study with prospectively ascertained data from the Skåne Healthcare Register
(SHR), Sweden, encompassing more than 15 million person-years of primary and specialist outpatient
care and hospitalizations. We studied all Skåne region residents aged 45 by the end of 2012 (n ¼ 531,
254) and determined the prevalence of doctor-diagnosed OA deﬁned as the proportion of the prevalent
population that had received a diagnosis of OA of the knee, hip, hand, or other locations except the spine
between 1999 and 2012. We projected consultation prevalence of OA until year 2032 using Statistics
Sweden's (SCB) projected age and sex structure and prevalence of overweight and obesity.
Results: In 2012 the proportion of population aged 45 with any doctor-diagnosed OA was 26.6% (95%
conﬁdence interval (CI): 26.5e26.8) (men 22.4%, women 30.5%). The most common locations were knee
(13.8%), hip (5.8%) and hand (3.1%). Of the prevalent cases 26.8% had OA in multiple joints. By the year
2032, the proportion of the population aged 45 with doctor-diagnosed OA is estimated to increase from
26.6% to 29.5% (any location), from 13.8% to 15.7% for the knee and 5.8e6.9% for the hip.
Conclusion: In 2032, at least an additional 26,000 individuals per 1 million population aged 45 years
are estimated to have consulted a physician for OA in a peripheral joint compared to 2012. These ﬁndings
underscore the need to address modiﬁable risk factors and develop new effective OA treatments.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a leading cause of pain and functional
impairment in working age adults and the elderly1e3. Number of
years lived with disability due to knee and hip OA alone increased
by 64% between 1990 and 2010 and OA is currently ranked eleventhA. Turkiewicz, Epidemiologi
d, Sweden. Tel: 46-46171392.
se (A. Turkiewicz), ingemar.
skane.se (J. Bj€ork), gillian.
med.lu.se (L.E. Dahlberg),
martin.englund@med.lu.se
ternational. Published by Elsevier Lin the world on the list of leading causes of years lived with
disability4. Between 1999 and 2007/2008 the number of total knee
replacements due to OA in the United States (US) and Scandinavia
more than doubled.5e7
However, patients who receive total joint replacement consti-
tute only a minority of all OA patients. While the twentieth century
prevalence and incidence of symptomatic or radiographic OA has
been extensively studied, the impact of OA on health care use has
been much less studied1,6,8e10. Further, disease occurrence in OA is
not in a steady state due to aging of the population and the major
risk factor for OA which is increased body mass index (BMI). For
instance, there is evidence that obesity increases the risk for knee
OA, but an increase in risk of hip and hand OA has been reported astd. All rights reserved.
Table I
ICD 10 system of OA
Location ICD 10 code Diagnosis
Knee M17 Gonarthrosis [arthrosis of knee]
Hip M16 Coxarthrosis [arthrosis of hip]
Hand/wrist M18 Arthrosis of ﬁrst carpometacarpal joint
M15.1 Heberden's nodes (with arthropathy)
M15.2 Bouchard's nodes (with arthropathy)
M19.0D Primary arthrosis of other joints, site:
wrist/hand
M19.1D Post-traumatic arthrosis of other joints,
site: wrist/hand
M19.2D Other secondary arthrosis, site: forearm







Other arthrosis (excluding arthrosis
in hand/wrist)
Any M25.5* Pain in joint
* The code for pain in joint was used only in the sensitivity analysis.
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projected to increase, it is expected that OA prevalencewill increase
as well15,16. The prevalence of self-reported doctor diagnosed
arthritis in US adults has been projected to increase from 22% in
2003 to 25% by 203017. Presently there is a substantial lack of valid
information on the future prevalence of OA leading to health care
seeking. Expected changes in disease occurrence require changes
in planning and resource prioritization. Hence, we posed two
important questions: What proportions of the population consult
due to OA at various joint sites? What proportions can be expected
to consult a physician in the future?
Methods
Data sources
The Skåne regionwith 1.26million inhabitants (by December 31,
2012) is located in southern Sweden, and contains both rural and
urban areas. Primary and specialist level healthcare is provided by
public and private payers through the same tax-based ﬁnancing
system. The patient's co-pay is similar irrespective of whether the
care is provided by a public or private healthcare provider and it is
common that patients seek care from, or are referred to, both types
of providers.
A personal identiﬁcation number is assigned to all Swedish
residents and provides information on age and sex. Swedish law
requires that all healthcare contacts are registered by the personal
identiﬁcation number, serving as the basis for reimbursement to
the healthcare provider. The Skåne Healthcare Register (SHR)
contains information about every healthcare contact made in the
region and includes data on healthcare provider, the profession
(physician, physical therapist etc.), type of contact (e.g., primary/
specialist care, in- or out-patient visit, clinic etc.) and contact date.
Furthermore, the register contains the publicly practicing physi-
cians' diagnostic codes according to the International Classiﬁcation
of Diseases (ICD) 10 system. These codes are assigned by the doc-
tors themselves and are retrieved from the electronic medical re-
cords to the register. The diagnostic codes assigned by privately
practicing physicians are not forwarded to the register (while other
details of the visit are).
The Swedish population register contains information about
vital events such as births, deaths, and changes in residential
address for all inhabitants in Sweden through the personal iden-
tiﬁcation number. The register is continuously updated by the
Swedish Tax Agency.
Statistics Sweden (SCB) provided us with individual information
on income, which we linked by the personal identiﬁcation number.
SCB also provided age and sex speciﬁc longitudinal data on the
prevalence of overweight and obesity and the population projec-
tion for Sweden until year 2032.
The study was approved by the Lund University Ethics
Committee.
Multiple imputation of missing diagnoses
Of all persons who had at least one health care visit to a physi-
cian during the study period, 96% had at least one ICD-10 code
registered. Of all physician health care visits 29.5% weremade in the
private care and had no diagnostic code registered, as the codes
from private care are not yet forwarded to the SHR (while other
details of the visits are). We considered these codes to bemissing at
random and adjusted for this18. Further, 15% of all physician health
care visits had no diagnostic code registered in the public health
care system. A majority of those visits were made in primary care
before the year 2004, as the registration of diagnostic codes wasless reinforced before 2004. We used multiple imputation to adjust
for missing diagnostic codes in both private and public healthcare
as detailed in web appendix A.19
Current point prevalence of doctor-diagnosed OA
First, as a measure of the current impact on health care, we
estimated the 2012 point prevalence of doctor-diagnosed OA,
deﬁned as the proportion of the population that, using data from
1999 onward, had been diagnosed with OA at least once and were
still alive, aged 45þ years and residing in the region as of December
31, 2012.
Hence, we retrieved data from all clinic visits with a physician at
a primary care unit or with a specialist (or a physician under spe-
cialty training) at an internal medicine, rheumatology, orthopedics,
rehabilitation, surgery (including hand surgery and oral and
maxillofacial surgery) or emergency medicine clinic made between
1999 and 2012 for all Skåne region residents aged 45 years or older
in 2012. Subjects who received a diagnosis of OA in any joint
(excluding the spine) at least once during this time period were
deﬁned as having ‘any OA’. Subjects were classiﬁed as having OA of
the knee, hip, hand or other joints, respectively, according to the
ICD-10 diagnosis received (Table I). In the prevalence calculation
each personwas counted only once. A personwith OA in more than
one location (knee, hip, hand or other) contributed to the preva-
lence of OA in every location where diagnosed. We then calculated
the prevalence of doctor-diagnosed OA by December 31, 2012 by
individual linkage with the population register to exclude all sub-
jects who had died or relocated from the region.
Validation of knee OA diagnosis in the register (positive predictive
value)
To validate if the SHR diagnosis of knee OA was correct we used
the population based Malm€o Osteoarthritis (MOA) study carried
out between 2007 and 200820e23. We obtained the positive pre-
dictive values of the knee OA diagnosis in the register as speciﬁed in
the web appendix B.
Projected prevalence of OA to 2032
We used the age and sex speciﬁc 2012 prevalence estimates of
doctor-diagnosed knee OA, hip OA, hand OA or ‘any OA’ to predict
the prevalence until 2032. First we used the sex and age speciﬁc (in
age categories: 45e49, 50e59, 60e69, 70e79, 80þ years)
A. Turkiewicz et al. / Osteoarthritis and Cartilage 22 (2014) 1826e18321828population projection provided by SCB and sex and age speciﬁc
prevalence estimates to project the future prevalence of OA due to
changes in the age and sex structure of the population. Further, we
used the observed sex and age speciﬁc prevalence of overweight
and obesity in Sweden measured by SCB in 1988, 2008 and 2010
(three measurements) to assess the impact of obesity on the future
prevalence of OA. We assumed that the linear increase observed
between 1988 and 2010 would continue until 2032. We used pre-
viously published results from meta-analyses and assumed that an
increase in BMI of ﬁve units (which represents moving one “full
step” from the normal weight category to overweight, or from
overweight to obese) increases the risk for incident OA by 1.35 for
the knee (1.22 for men and 1.38 for women) and 1.11 for hip and
hand (for both men and women)24,25. As 50% of all 2012 prevalent
OA cases had knee OA, we assumed the risk for ‘any OA’ equal to the
mean of those for knee and hip. The calculations were made
using the following formula linking the prevalence proportions
and incidence rates: (number of prevalent OA)*(1/disease
duration) ¼ incidence*(number of people in population-number of
prevalent OA), wherewe assumed that the disease duration is equal
to the life expectancy at the mean age of subjects with OA in our
cohort14 (Table II). The years of life expectancy for those aged 65 in
the year 2012 were retrieved from SCB publications. The estimates
of the prevalence of overweight, obesity and the years of life ex-
pectancy as well as the exact formulas used to derive projections
are available in web appendix C.
To assess sensitivity of the projections with respect to as-
sumptions on BMI increase and its impact on risk of OA we modi-
ﬁed the risk rates for incident OA to be equal with their lower or
upper conﬁdence limits, i.e., 1.23 (lower limit) or 1.54 (upper limit)
for knee OA in women, 1.19 or 1.25 for knee OA in men and 1.07 or
1.16 for hip and hand OA24,25. Second, we modiﬁed the projected
prevalence of overweight and obesity and assumed that the in-
crease would be 10% lower or 10% higher than the one observed
between 1988 and 2010.Statistical analysis
We used a logit regression model to obtain the prevalence es-
timates with conﬁdence intervals (CI). In a sensitivity analysis, we
repeated the analyses using an expanded deﬁnition for OA, which
incorporated a diagnosis of pain in joint (ICD-10 code: M25.5, no
location speciﬁed) at age 55 years or older10. All presented preva-
lence numbers were based on the imputed data. Analyses were
performed using R (R Core Team) and STATA 13.
Results
Current point prevalence of doctor-diagnosed OA
The current proportion of the population aged 45 (n ¼ 531,
254, 52% women) that had any doctor-diagnosed OA between 1999
and 2012 was 26.6% (95% CI: 26.5, 26.8). The prevalence in menwas
22.4% (95% CI: 22.2, 22.6) and in women 30.5% (95% CI: 30.3, 30.7).
The most common location was the knee joint with the prevalence
of 13.8% (95% CI: 14.7, 13.9) followed by other joints, 12.4% (95% CI:
12.3, 12.5), hip, 5.8% (95% CI: 5.7, 5.9) and hand, 3.11% (95% CI: 3.06,Table II
The mean age of OA subjects in the SHR, by sex and OA location
Knee OA Hip OA Hand OA Any OA
Women 68.1 72.0 65.6 70.0
Men 66.5 70.9 67.2 67.63.16). The prevalence typically increased with increasing age and
was higher in women (Table III).
Of all OA cases, 26.8% had been diagnosed with OA in more than
one location. Knee OA and OA of other joints was themost common
combination (10.9%). (Figure 1) Of all hand OA cases 53.6% had been
diagnosed with OA in at least one other location.
When we expanded our OA deﬁnition to include a diagnostic
code for ‘joint pain’ (location not speciﬁed) in those aged 55 years
or older, the 2012 prevalence of OA in the population 45 was
estimated to be 42.3% (36.4% in men and 47.7% in women).
Validation of knee OA diagnosis in the register (positive predictive
values)
The probability of an ICD-10 code M17 diagnosis (knee OA) in
the SHR to be in a MOA study subject fulﬁlling either the American
Colleague of Rheumatology (ACR) clinical & radiographic criteria
(with respect to the side) or having radiographic knee OA equiva-
lent to Kellgren/Lawrence grade  2 was 88%.
Projected prevalence of OA to 2032
Taking into account only the projected changes in the sex-age
structure of the population the prevalence of ‘any OA’, knee OA
and hip OA, respectively, is expected to increase from 26.6% to
29.0%, from 13.8% to 15.2% and from 5.8% to 6.8%, respectively over
the next two decades. When accounting additionally for the in-
crease in the estimated prevalence of overweight and obesity the
prevalence of ‘any’ OA, knee and hip OAmay increase from 26.6% to
29.5%, from 13.8% to 15.7% for the knee and 5.8e6.9% for the hip,
respectively. The pattern was similar for men and women (Fig. 2).
This corresponds to the relative increase of 10%, 12% and 18%,
respectively. Thus, by 2032 there may be over 26,000 more doctor
diagnosed OA prevalent cases per 1,000,000 population aged 45 or
older as compared to 2012. The gray areas in Fig. 2 show the impact
of different assumptions on the increase in prevalence of over-
weight and obesity and its impact on the risk of OA as speciﬁed in
the sensitivity analyses.
Discussion
We examined the current impact of OA on the health care sys-
tem by determining the proportion of the population with doctor
diagnosed OA using 14 years of comprehensive Swedish health
register data. Currently, one in four adults aged 45 has doctor-
diagnosed OA in at least one joint, excluding the spine, and more
than one in eight had doctor-diagnosed OA of the knee. We also
made projections over the next two decades. These projections
indicate that almost 30% of adults aged45 in 2032 are expected to
have consulted for OA by 2032 and half of those for knee OA.
In our report the prevalence of OA in any location excluding
spine in adults aged 45 that had led to healthcare consultation
was 26.6%, higher than the prevalence in 2001 reported from
Canada26. The prevalence of self-reported doctor-diagnosed OA in a
Norwegian survey of 44e76 year-olds was 10.7% for knee and 8.7%
for hip27. Our estimates (10.9% and 3.6%) in the corresponding age
group are lower for the hip but may be explained by 43% nonre-
sponse in the Norwegian survey that was not adjusted for, or recall
bias. Prevalence of symptomatic OA (combining radiographic evi-
dence and pain in the symptomatic joint in epidemiologic studies)
in those aged 45 varies between studies from 6.7% to 15.9% in the
knee and 1.6% to 9.2% in the hip1,8,9,28. Our estimates of clinically
relevant OA of 13.8% in the knee and 5.8% in the hip are in the
middle of this range. The prevalence of symptomatic hip OA in
Fig. 1. The 2012 site distribution of OA that burdens health care and its overlap in adults aged45. Numbers are percentages of all cases with OA. Other e includes OA of joints other
than knee, hip and hand such as shoulder, elbow, ankle and foot, jaw and polyarthrosis (excluding Bouchard's and Heberden's nodes as those are included in the hand). Other
combinations e includes all combinations of knee, hand, hip and other, not already listed in a pie. Spine is not included.
A. Turkiewicz et al. / Osteoarthritis and Cartilage 22 (2014) 1826e1832 1829Johnston County OA Project was 9.2% and our estimate of 5.8% can
be expected as not all symptomatic patients seek care.9
Asmany as one in four of the prevalent OA cases were diagnosed
with the disease at multiple joint sites. In a study of symptomatic
limb joint OA patients attending a rheumatologist in Bristol, United
Kingdom, where both clinical symptoms and radiographic changes
in the symptomatic joint were required for the diagnosis, 50% of the
study sample was diagnosed with the disease in multiple joints29.
However, substantially more severe OA cases are to be expected at a
rheumatology clinic than in health care in general. The associations
found in the literature between knee OA or hip OA and hand OA are
classically based on radiographic deﬁnition of the disease, but has
been shown even for clinically diagnosed OA30,31. In our study, 26%
of patients with doctor-diagnosed hand OA were diagnosed with
OA of knee and 11% with OA of the hip. The OA cases with multiple
sites involved might require more healthcare resources than others
which warrant more research to understand the implications of
their disease.
We projected a relative increase on 10% over two decades (by
year 2032) in the occurrence of ‘any OA’ that leads to health care
consultation taking into account the future age and sex structure of
the population as well as the prevalence of overweight and obesity.Table III
The 2012 population prevalence (%) and 95% CIs (in parentheses) of OA that burdens healt
and hand such as shoulder, elbow, ankle and foot, jaw and polyarthrosis (excluding Bouch
Age (years)
45e54 55e64 65e74
Knee OA All 4.1 (3.9e4.2) 10.3 (10.1e10.5) 17.5 (17
Men 4.0 (3.8e4.1) 9.2 (9.0e9.5) 16.1 (15
Women 4.1 (4.0e4.3) 11.3 (11.0e11.6) 19.0 (18
Hip OA All 0.8 (0.8e0.9) 2.3 (2.3e2.4) 7.0 (6.9
Men 0.8 (0.7e0.9) 2.3 (2.2e2.4) 6.5 (6.3
Women 0.8 (0.7e0.9) 2.4 (2.3e2.5) 7.5 (7.3
Hand OA All 0.9 (0.9e1.0) 3.1 (3.0e3.1) 4.7 (4.6
Men 0.4 (0.4e0.5) 1.4 (1.3e1.5) 2.5 (2.3
Women 1.4 (1.3e1.5) 4.7 (4.5e4.8) 6.9 (6.7
Other OA All 3.4 (3.3e3.5) 9.9 (9.8e10.1) 16.4 (16
Men 2.9 (2.8e3.1) 7.7 (7.5e7.9) 13.1 (12
Women 3.9 (3.7e4.0) 12.2 (11.9e12.4) 19.6 (19
Any OA All 8.2 (8.0e8.4) 21.1 (20.9e21.4) 34.8 (34
Men 7.4 (7.2e7.6) 17.6 (17.4e18.0) 30.3 (29
Women 9.0 (8.8e9.2) 24.6 (24.3e25.0) 39.1 (38This increase is higher that the projected increase of self-reported
doctor diagnosed arthritis from 29.6% in 2010 to 31.7% of the US
population aged 20 when only change in age structure was
accounted for32. Our estimates are lower than those of other re-
searchers in US and Canada who reported projections of the
prevalence of self-reported arthritis with relative increase that
ranged from 16 % to 50% within two decades in population aged 15
or older17,33. In a 2011 national report from Canada the projected
increase in the prevalence of OA in any location by the year 2030
compared to 2010 was 75% for the whole population34. Those re-
sults reﬂect to a high extent the expected shift in the population
structure of USA and Canada with a higher share of older adults.
This shift didn't affect our results to the same extent as we used the
age group 45 or older, a group typically affected by OA. Compari-
sons with other countries are challenging also due to different
current and projected age and sex structures. Furthermore, our
projection didn't take into account the potential for increased
awareness of OA in the society which would increase the pro-
pensity to consult health care. The current high prevalence of
obesity and its expected increase in the populations over the world
is another important factor that will affect the future prevalence of
OA, especially of the knee35. Our results indicate though that theh care, by age, sex and joint site. Other OA- includes OA of joints other than knee, hip
ard's and Heberden's nodes as those are included in the hand). Spine is not included.
75e84 85þ 45þ
.3e17.8) 25.9 (25.4e26.3) 30.8 (30.2e31.4) 13.8 (13.7e13.9)
.7e16.4) 23.4 (22.8e24.0) 27.4 (26.4e28.6) 12.0 (11.9e12.2)
.6e19.3) 27.8 (27.2e28.4) 32.4 (31.7e33.1) 15.5 (15.3e15.6)
e7.2) 14.8 (14.5e15.1) 17.9 (17.5e18.4) 5.8 (5.7e5.9)
e6.7) 13.5 (13.1e14.0) 17.5 (16.7e18.3) 5.0 (4.9e5.1)
e7.8) 15.7 (15.3e16.1) 18.2 (17.6e12.5) 6.5 (6.3e6.7)
e4.8) 4.6 (4.4e4.7) 3.5 (3.3e3.7) 3.1 (3.1e3.2)
e2.6) 2.8 (2.6e3.0) 2.4 (2.1e2.7) 1.6 (1.6e1.7)
e7.1) 5.9 (5.7e6.2) 4.0 (3.7e4.3) 4.5 (4.4e4.6)
.2e16.6) 22.0 (21.6e22.4) 25.0 (24.3e25.7) 12.4 (12.3e12.5)
.8e13.4) 18.0 (17.4e18.5) 21.0 (19.8e22.2) 9.6 (9.4e9.7)
.2e20.0) 25.1 (24.5e25.6) 26.9 (26.2e27.7) 14.9 (14.8e15.1)
.5e35.1) 47.5 (47.0e47.9) 53.1 (52.4e53.7) 26.6 (26.5e26.8)
.8e30.8) 42.7 (42.0e43.3) 48.8 (47.6e50.1) 22.4 (22.2e22.6)
.6e39.6) 51.2 (50.6e51.8) 55.2 (54.5e55.9) 30.5 (30.3e30.7)
Fig. 2. The 2012 prevalence and the projection for years 2013e2032 of OA that burdens health care. The projection is based on the predicted changes in age-structure of the
Swedish population, predicted increase in the age and sex speciﬁc prevalence of overweight and obesity in Sweden and differential effects of increased BMI on different joint sites.
The lower boundary of the gray area shows the projected prevalence when assuming the impact of BMI on the incidence of OA equal to the lower conﬁdence level and the increase
in the prevalence of overweight and obesity 10% lower than that observed in Sweden between 1988 and 2010. Accordingly, the upper bound of the gray area show the projected
prevalence assuming the impact of BMI equal to its upper conﬁdence level and the increase in the prevalence of overweight and obesity 10% higher than that observed in Sweden
between 1988 and 2010.
A. Turkiewicz et al. / Osteoarthritis and Cartilage 22 (2014) 1826e18321830highest relative increase is to be expected in the hip OA. This is due
to the greatest population growth in those aged 70 or older, where
the hip OA is highly prevalent.
As a measure of impact on health care, we estimated the
location-speciﬁc as well as the overall occurrence of doctor-
diagnosed OA based on 14 years of data in a register with vali-
dated ICD-10 codes covering a well-deﬁned population. This
approach enables direct interpretation in terms of healthcare uti-
lization. Naturally, myriad factors impact consultation patterns
beyond the actual occurrence of disease. The capacity of health care
systems may change, the policies and national campaigns focusing
on different aspects of health may inﬂuence patients' willingness to
consult or receive a treatment. Easier access to healthcare for per-
sons with OA, through e.g., care programs such as ‘Better man-
agement of OA’ in Sweden or Affordable Care Act in US, may result
in an increase of number of persons consulting for OA but also
contribute to alleviating the consequences of the increasing prev-
alence of OA. As the number of effective drugs for the treatment of
OA is limited, and no widely accepted disease modifying inter-
vention exists, there appear to be no reasons for the burden of OA
on health care to plateau (or decline) within the next two decades.
The expected increase in OA occurrence poses a growing threat to
public health as also proven by historical data4. OA accounts for asubstantial number of healthcare visits in populations with access
to medical care and caused 6.8% of all disability adjusted life years
in 2010, an increase from 2% reported in 200410,36. Between 1991
and 2010 the number of knee replacement surgeries increased by
162% for those aged 65 or older in the US, a 673% increase in rates is
projected by 2030.15,37
Importantly, our aim was not to estimate the occurrence of OA
disease in general but only the occurrence of OA that directly
impacts the health care system in terms of visits to a physician.
That is undoubtedly an underestimation of the “true” prevalence
of the disease as about 40% of symptomatic knee OA patients
identiﬁed in the Malm€o OA study hadn't consulted a physician
due to knee OA or knee pain or didn't receive those diagnoses
during the 3 years preceding the study examination (unpublished
data). Primary care physicians may have difﬁculties with clinical
examination of musculoskeletal disorders that could bias our es-
timates38. However, specialist care is relatively easily accessed in
Sweden (even without referral from a primary care physician) and
we used data over a 14-year period. In the Skåne region the
formal guidelines for the diagnosis of OA were implemented ﬁrst
in 2012. The diagnoses registered between 1999 and 2011 were
based on the physicians' clinical judgment. However, the validity
of rheumatic diagnoses in the SHR has been shown to be high39,40.
A. Turkiewicz et al. / Osteoarthritis and Cartilage 22 (2014) 1826e1832 1831In the present study, we performed an extensive validation for
knee OA against a number of OA criteria. The positive predictive
value of knee OA diagnosis in SHR was 88% and is higher than for
example in the Massachusetts health maintenance organization
for OA in any location.41
Our projections took into account the future age and sex
structure of the population and the future prevalence of over-
weight and obesity. There are other factors, such as the incidence
of knee injuries or willingness to consult that will impact the
future prevalence of doctor-diagnosed OA. The uncertainty of the
population projections, the assumed increase in the prevalence of
overweight and obesity and risk for developing OA at different
joints sites all contribute to the uncertainty of the projection. We
assumed that the linear increase in the prevalence of overweight
and obesity observed between 1988 and 2010 would continue in
the next 20 years, which might not hold true, e.g., if effective
prevention programs will be implemented. We assumed the same
mortality in persons with and without OA which could bias our
estimates upwards if patients with OA will experience signiﬁcantly
higher mortality than the general population. The 2012 net
immigration in the Skåne region was 0.07% of the population aged
45 or older and thus we expect that migration would have a
negligible effect of the projected estimates when accounting for an
increase in BMI. As we have studied the population aged 45 or
older, we were not able to assess the potential increase in preva-
lence in younger patients.
Our results show that in 2012 almost one in seven adults aged
45 in Southern Sweden had doctor-diagnosed OA of the knee. As
the 2012 prevalence of persons with knee prosthesis aged 45 in
Swedenwas 2.3%, it implies that 17% of prevalent doctor-diagnosed
knee OA cases have undergone knee replacement surgery (un-
published data). By 2032, over 26,000 new OA cases per 1,000,000
population aged 45 or older will have consulted healthcare. To a
large extent it will be the primary care physicians who will face the
increased workload but a crisis in supply of total joint replacement
surgery is also anticipated42,43. This will put a considerable stress
on the health care system. In most western European countries the
age of retirement is increasing and therefore, the future work force
will include an increasing number of individuals suffering from OA.
Prioritization of research on population health strategies to reduce
OA, including weight loss and knee injury prevention, and, for
those affected by OA, the development of effective therapies is
needed. Further research on the burden of OA on health care is
needed to evaluate the accuracy of these projections, especially
since many previous predictions of both the incidence of surgery in
OA and the prevalence of arthritis have been far outgrown by
reality.33
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